
Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma
Author(s) -
JiBin Liu
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i44.4917
Subject(s) - wnt signaling pathway , dna methylation , methylation , cancer research , esophageal squamous cell carcinoma , biomarker , medicine , odds ratio , oncology , promoter , microbiology and biotechnology , carcinoma , gene , biology , gene expression , genetics
To detect the effects of plasma DNA methylation of Wnt antagonists/inhibitors on recurrence of esophageal squamous cell carcinoma (ESCC).